SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Laura-Maria Krabbe, Robert S. Svatek, Shahrokh F. Shariat, Edward Messing, Yair Lotan, Bladder cancer risk: Use of the PLCO and NLST to identify a suitable screening cohort, Urologic Oncology: Seminars and Original Investigations, 2015, 33, 2, 65.e19

    CrossRef

  2. 2
    Maxine Sun, Quoc-Dien Trinh, Diagnosis and Staging of Bladder Cancer, Hematology/Oncology Clinics of North America, 2015, 29, 2, 205

    CrossRef

  3. 3
    Grant Izmirlian, Jon Paciorek, In reply to Krabbe et al, Urologic Oncology: Seminars and Original Investigations, 2015, 33, 1, 49

    CrossRef

  4. 4
    Andrea B. Apolo, Vanessa Hoffman, Matthew G. Kaag, David M. Latini, Cheryl T. Lee, Jonathan E. Rosenberg, Margaret Knowles, Dan Theodorescu, Bogdan A. Czerniak, Jason A. Efstathiou, Matthew L. Albert, Srikala S. Sridhar, Vitaly Margulis, Surena F. Matin, Matthew D. Galsky, Donna Hansel, Ashish M. Kamat, Thomas W. Flaig, Angela B. Smith, Edward Messing, Diane Zipursky Quale, Yair Lotan, Summary of the 8th Annual Bladder Cancer Think Tank: Collaborating to move research forward, Urologic Oncology: Seminars and Original Investigations, 2015, 33, 2, 53

    CrossRef

  5. 5
    Laurence Klotz, Maurizio A. Brausi, World Urologic Oncology Federation Bladder Cancer Prevention Program: A global initiative, Urologic Oncology: Seminars and Original Investigations, 2015, 33, 1, 25

    CrossRef

  6. 6
    Bernd J. Schmitz-Dräger, Tilman Todenhöfer, Bas van Rhijn, Beate Pesch, Mĺiss A. Hudson, Ashish Chandra, Molly A. Ingersoll, Wassim Kassouf, Joan Palou, John Taylor, Antonia Vlahou, Thomas Behrens, Rossana Critelli, H. Barton Grossman, Marta Sanchez-Carbayo, Ashish Kamat, Considerations on the use of urine markers in the management of patients with low-/intermediate-risk non–muscle invasive bladder cancer, Urologic Oncology: Seminars and Original Investigations, 2014, 32, 7, 1061

    CrossRef

  7. 7
    J. Schiffmann, G. Gandaglia, A. Larcher, M. Sun, Z. Tian, S.F. Shariat, M. McCormack, L. Valiquette, F. Montorsi, M. Graefen, F. Saad, P.I. Karakiewicz, Contemporary 90-day mortality rates after radical cystectomy in the elderly, European Journal of Surgical Oncology (EJSO), 2014, 40, 12, 1738

    CrossRef

  8. 8
    Evanguelos Xylinas, Luis A. Kluth, Malte Rieken, Pierre I. Karakiewicz, Yair Lotan, Shahrokh F. Shariat, Urine markers for detection and surveillance of bladder cancer, Urologic Oncology: Seminars and Original Investigations, 2014, 32, 3, 222

    CrossRef

  9. 9
    Helena Furberg, Bernard H. Bochner, Bladder cancer: Towards risk stratification in bladder cancer, Nature Reviews Urology, 2013, 10, 7, 374

    CrossRef

  10. 10
    Maurizio A. Brausi, Primary Prevention and Early Detection of Bladder Cancer: Two Main Goals for Urologists, European Urology, 2013, 63, 2, 242

    CrossRef

  11. 11
    Stéphane Larré, James W.F. Catto, Michael S. Cookson, Edward M. Messing, Shahrokh F. Shariat, Mark S. Soloway, Robert S. Svatek, Yair Lotan, Alexandre R. Zlotta, H. Barton Grossman, Screening for Bladder Cancer: Rationale, Limitations, Whom to Target, and Perspectives, European Urology, 2013, 63, 6, 1049

    CrossRef